Searchable abstracts of presentations at key conferences in endocrinology

ea0029s62.2 | Early Development and Treatment of PCOS | ICEECE2012

Early development and pubertal prevention of polycystic ovary syndrome

de Zegher F. , Ibanez L.

PCOS (defined by NIH, Rotterdam or AES criteria) is traditionally viewed as an ovarian disorder that appears in adolescence and may lead to metabolic complications in adulthood. Emerging evidence, however, indicates that PCOS is primarily a disorder of adipose-tissue hyperexpansion that may originate in early life, develop across childhood and puberty, and advance into end-stage disease (including ovulatory dysfunction and ovarian androgen excess) by adolescence. Prepubertal m...

ea0029p917 | Female Reproduction | ICEECE2012

Treatment of androgen excess in adolescent girls: ethinylestradiol–cyproteroneacetate vs low-dose pioglitazone–flutamide–metformin

Ibanez L. , Diaz M. , Rodriguez-Chacon M. , Maymo-Masip E. , Salvador C. , Lopez-Bermejo A. , Vendrell J. , de Zegher F.

Objective: To compare the effects of a classic therapy to those of a novel treatment for androgen excess in adolescent girls.Study design: Randomized, open-labeled trial over 12 months.Study participants: Adolescents (n=34; mean age 16 year, BMI 23 kg/m2) with hyperinsulinemic androgen excess and without risk of pregnancy.Interventions: Ethinyl estradiol-cyproterone acetate (EE-CA; Diane 35 ...